Trian In DuPont Move

Aug 16 2013 | 1:18am ET

Activist hedge fund Trian Fund Management has amassed a huge stake in chemical giant DuPont Co. and has already begun pushing for changes.

Trian, led by Nelson Peltz, has bought a 2.2% stake in DuPont worth $1.3 billion. And Peltz has wasted no time, having already met with DuPont CEO Ellen Kullman and other senior executives.

According to the Wilmington News-Journal, Peltz presented DuPont with one of his famous white papers, suggesting how to boost shareholder value and improve long-term growth prospects.

"We will evaluate any ideas Trian may have in the context of our ongoing initiatives to build a higher value, higher growth company for our shareholders," DuPont spokesman Michael Hanretta said.

DuPont this week adopted several poison pills, including provisions that would pay executives larger severance and changing the way that board candidates are nominated.


In Depth

Exotic Assets: Investing In Rare Violins

Jan 17 2017 | 4:43pm ET

By definition, alternative investments include exotic assets far beyond your typical...

Lifestyle

'Tis the Season: Wall Street Holiday Parties Back In Fashion

Dec 22 2016 | 9:23pm ET

Spending on Wall Street holiday parties has largely returned to pre-2008 levels...

Guest Contributor

DarcMatter: The Top Trends in Alternative Investments for 2017

Jan 13 2017 | 8:22pm ET

The $7 trillion alternative investments industry is poised for continued growth...

 

From the current issue of

The U.S. Commodity Futures Trading Commission (CFTC) ordered The Goldman Sachs Group Inc., and Goldman, Sachs & Co. to pay a $120 million penalty for attempted manipulation and false reporting of ISDAFIX Benchmark Rates, a global benchmark for interest rate products.